Monitoring of fibrinolysis parameters during myocardial revascularization according to type of procedure

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 1, 2005, Pages 43-48

  Živković, Marcela ^a   Brkić, Kristina ^a   Nikić, Nada ^a   Hašperger, Dragica ^a   Juriček, Jasna ^a   Husedžinović, Ino ^a   Sutlić, Željko ^a  

^a University of Zagreb School of Medicine   (Croatia)

Author keywords

Cardiopulmonary bypass; D dimers; Fibrinoloysis plasminogen activator inhibitor (PAI I); Plasminogen

Indexed keywords

D DIMER; HEPARIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; PROTAMINE;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; HEART MUSCLE REVASCULARIZATION; HEMATOLOGICAL PARAMETERS; HEMODYNAMICS; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MEDICAL ASSESSMENT; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURGICAL TECHNIQUE; THORAX SURGERY;

AGED; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; EXTRACORPOREAL CIRCULATION; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 14244251246     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2005.006     Document Type: Article

References (25)

1. Shore-Lesserson L. Point-of-care coagulation monitoring for cardiovascular patients: past and present. J Cardiothorac Vasc Anesth 2002;16:99-106.
2. Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management Anesthesiology 2002;97:837-41.
3. Kojima T, Gando S, Morimoto Y, Mashio H, Goda Y, Kawahigashi H, et al. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery. Thromb Res 2001;104:301-7.
4. Despotis GJ, Avidan MS, Hogue CW Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001;72: S1821-31.
5. Stein CM, Brown N, Vaughan DE, Lang CC, Wood AJ. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J Am Coll Cardiol 1998;32:117-22.
6. Sutlić Ž, Unić D, Rudež I, Biočina B, Barić D, Kontić M. Implantation of aortic stentless bioprosthesis: case series. Croat Med J 2002;43:409-11.
7. Biočina B, Sutlić Ž, Rudež I, Barić D, Unić D, Štambuk B. Multiple arterial off-pump coronary artery bypass grafting: a 5-year experience with clinical results. Heart Surg Forum 2003;6:132-4.
8. McColl AJ, Keeble T, Hadjinikolaou L, Cohen A, Aitkenhead H, Glenville B, et al. Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem 1998; 35:616-23.
9. Fears R, Esmail AF, Greenwood HC. Effect of heparin on the fibrinolytic response to plasminogen activators. Semin Thromb Hemost 1991;17:389-93.
10. Bruce D, Spiess MD. Heparin: beyond an anticoagulant. In: Society of Cardiovascular Anesthesiologists. The relationship between coagulation, inflammation and endothelium - a pyramid towards outcome. Philadelphia: Wolters Kluwer Company, 2000:169-89.
11. Casati V, Gerli C, Franco A, Della Valle P, Benussi S, Alfieri O, Torri G, et al. Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiology 2001;95:1103-9.
12. Hunt BJ, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg 1998;65:712-8.
13. Casati V, Della Valle P, Benussi S, Franco A, Gerli C, Baili P, et al. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg 2004; 128:83-91.
14. Kongsgaard UE, Smith-Erichsen N, Geiran O, Bjornskau L. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery. Thorac Cardiovasc Surg 1989;37:158-62.
15. Khuri SF, Valeri CR, Loscalzo J, Weinstein MJ, Birjiniuk V, Healey NA. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 1995;60:1008-14.
16. Comunale ME, Carr JM, Moorman RM, Robertson LK. Significance of D-dimer concentrations during and after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1996;10:477-81.
17. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985;29:236-61.
18. Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, et al. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res 1983; 31:767-78.
19. Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, et al. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies. Thromb Hemost 1983;50:591-4.
20. Whitaker AN, Elms MJ, Masci PP, Bundensen PG, Rylatt DB, Webber AJ, et al. Measurement of crosslinked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies. J Clin Pathol 1984;37:882-7.
21. Marder VJ, Budzynski AZ, Barlow GH. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin. Biochim Biophys Acta 1976;427:1-14.
22. Gaffney PJ, Joe F. The lysis of crosslinked human fibrin by plasmin yields initially a single molecular complex, D-dimer-E. Thromb Res 1979;15:673-87.
23. Dempfle C-E. Use of D-dimer assays in the diagnosis of venous thrombosis. Semin Thromb Hemost 2000; 26:631-41.
24. Stowe Rinder C. Platelets and their interactions. In: Society of Cardiovascular Anesthesiologists. The relationship between coagulation, inflammation and endothelium - a pyramid towards outcome. Philadelphia: Wolters Kluwer Company, 2000:107-28.
25. Wagner C. Plasminogen activators (PA), plasminogen activator inhibitor (PAI). In: Thomas L, editor. Clinical laboratory diagnostics. Frankfurt/Main: TH-Books Verlagsgesellschaft mbH, 1998:638-40.